Juniper Biologics at a glance

Juniper Biologics is a leading specialty pharmaceutical company focused on commercializing a portfolio of products in the areas of oncology, oncology support care, rare diseases, and gene ad cell therapy. Juniper was formed through the management buyout of a team of seasoned pharma professionals who had a successful track record of building world class life sciences companies.

Impact Story

Juniper Biologics anchor platform of oncology drugs aims to improve the quality of life of cancer patients by increasing access to essential medicines to regions historically underserved while ensuring affordable price points compared to alternative options available. Juniper works closely with local and regional distributors, providers and patients in its target market to improve the reach of its in-licensed medicines while focusing on future innovations to treat other illnesses.